Intech Biopharm Corporation announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced total revenue was TWD 4.026 million compared to TWD 3.993 million a year ago. Operating loss was TWD 74.890 million compared to TWD 63.670 million a year ago. Net loss was TWD 77.120 million compared to TWD 62.068 million a year ago. Basic loss per share was TWD 0.96 compared to TWD 0.78 a year ago. For the half year, total revenue was TWD 8.316 million compared to TWD 8.197 million a year ago. Operating loss was TWD 142.352 million compared to TWD 118.356 million a year ago. Net loss was TWD 145.849 million compared to TWD 112.662 million a year ago. Basic loss per share was TWD 1.82 compared to TWD 1.5 a year ago.